Treatment patterns in >3000 sorafenib-treated patients: final analysis of GIDEON (Global Investig

来源 :第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 | 被引量 : 0次 | 上传用户:wenfei87827
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To evaluate sorafenib (Sor) use in clinical practice in patients with hepatocellular carcinoma (HCC).Methods:GIDEON is a prospective, international, observational study.Patients with diagnosed HCC and for whom a decision to treat with Sor had been made in clinical practice were eligible.Patients were enrolled from 5 regions: Asia-Pacific (AP), Japan, Europe, USA, and Latin America.
其他文献
Objective: To establish a prognostic index model for advanced pancreatic cancer patients receiving palliative chemotherapy based on clinical variables.Method: The clinical data of 59 patients with adv
会议
Objective: compare the clinical characteristics and prognosis of Uyghur patients with hepatocellular carcinoma (HCC) in Xinjiang, China.Method: We retrospectively analysed the clinical data of 301 Uyg
会议
Objective: As an important treatment for thoracic cancers, radiotherapy (RT) can cause definite cardiotoxicity, even with modem techniques, such as 3D-CRT and IMRT.This prospective study was initiated
会议
目的:了解中国近年乳腺癌患者治疗现状,以推进国内乳腺癌规范化治疗的进行;评估卡培他滨联合化疗后续卡培他滨单药维持治疗的疗效和安全性.方法:共分析1680例一线或者二线使用卡培他滨联合化疗(XT/XP/XN/其他)的晚期乳腺癌患者,其中进入卡培他滨单药维持化疗的患者1235例.
会议
Objective: Neoadjuvant chemotherapy draws more attention these years due to many theoretical advantages, of which better compliance is one, however, it hasnt been fully proved.We aimed to compare the
会议
Objective: Gastric cancer is a common cancer with relatively poor survival rates.Gastric resection and intravenous chemotherapy are the current accepted standard treatment.Intraperitoneal chemotherapy
会议
Objective: Gastric cancer is one of the most common malignant tumors in China and radical gastrectomy remains the only way to cure it.Total gastrectomy, as a frequently used operation in gastric cance
会议
Objective: The new oral multi-kinase inhibitor REG improves overall survival (OS) in mCRC patients who progress after standard therapies.CONCUR (NCT01584830) evaluated the efficacy and safety of REG i
会议
Objective: To compare the long-term survival of operated and non-operated colon cancer (CC) in young patients with elderly ones.Method: Using Surveillance, Epidemiology, and End Results (SEER) populat
会议
目的:本研究拟通过三阴性乳腺癌有关的免疫标记物的表达、临床表现及生物学行为等一系列研究,探讨具有基底细胞样表型的三阴性乳腺癌的临床病理特征及预后相关因素.方法:收集128例1999年1月-2006年12月术前未接受任何治疗、无第二原发肿瘤的ER、PR、HER2阴性乳腺癌患者的临床病理资料,追踪随访患者生存信息,复阅切片,择取有代表性的肿瘤组织,应用组织微阵列技术、免疫组化染色技术,检测ER、PR、
会议